Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Grace Skemp-dymond (NPI 1720493273)

Field	Value
Entity Type	Individual
Organization	Grace Skemp-dymond
Address	7600 France Ave S Ste 5100
City	Edina
State	MN
ZIP	55435
Taxonomy	Rheumatology Physician
NPI Enumerated	June 24, 2014

Payer Source	Total Paid
Medicare	$971.4K
Medicaid	$0

Key Findings

GRACE SKEMP-DYMOND is a rheumatology physician enumerated on 2014-06-24 (~12 years ago) with lifetime Medicare revenue of $971.4K and no Medicaid billing on file. The absence of any Medicaid claims makes this an effectively single‑payer (Medicare) billing profile, concentrating reimbursement exposure to federal programs rather than state Medicaid contracts.

Revenue is highly concentrated in a small set of infusion drugs: the precomputed top three Medicare codes (J1745, J9312, J0129) account for 64.5% of the provider's total Medicare revenue. Individually those codes contribute 26.0% (J1745), 23.3% (J9312), and 15.1% (J0129) of Medicare revenue, indicating reliance on a handful of high-cost biologic administrations.

The code mix and volumes indicate an infusion‑centric rheumatology practice: J1745 (infliximab), J9312 (rituximab), J0129 (abatacept), J1602 (golimumab), and J3262 (tocilizumab) are all biologic injection/infusion products commonly used for autoimmune disease management, and the practice also reports chemotherapy/infusion administration codes (96413, 96415). In particular, 96415 shows 333 claims, $22 avg paid/claim, $7.3K revenue and is flagged as "notably above typical national volume for this code," suggesting above‑average prolonged infusion activity relative to peers.

Competitive standing across the top biologics is mixed: J1745 appears relatively prominent with rank #101 of 1352 providers nationally (93th percentile) but is still labeled in the data as "typical, unremarkable volume for this code," while J9312 ranks #137 of 317 (56th percentile) and J0129 ranks #959 of 1221 (21th percentile), both also reported as "typical, unremarkable volume." This pattern suggests stronger-than-average placement for some infusion products but overall participation that falls within customary ranges for rheumatology infusion providers rather than indicating national dominance.

Clinical support services and office visits form a secondary revenue stream: 99214 accounts for 387 claims and $34.1K (3.5% of Medicare revenue), while routine labs such as 85025 (347 claims, $2.8K) and liver enzymes 84450/84460 (each 368 claims, $1.8K) are regularly billed and rank in typical national percentiles. The presence of disease‑directed diagnostics—e.g., 86200 (CCP antibody, 32 claims, $416)—aligns with an outpatient rheumatology practice focused on autoimmune disease diagnosis and monitoring.

There is a notable utilization skew within biologics: J3262 (tocilizumab) shows high claim counts (16.1K claims) but low average paid/claim ($5) and is ranked #541 of 618 providers nationally (12th percentile), indicating relatively low revenue per claim and below‑peer revenue positioning for that specific agent. Conversely, J1745 and J9312 drive large shares of revenue (26.0% and 23.3% respectively), underscoring that revenue sensitivity is concentrated in a few branded infusion products.

From an operational and payer risk perspective, the combination of concentrated revenue (top three codes = 64.5%) and reliance on infusion/infusive administration codes means reimbursement shifts for key biologics or changes in infusion site-of-care policy could materially affect overall revenue. The provider’s lack of Medicaid billing further magnifies exposure to Medicare policy and rate changes, and the "notably above typical" volume signal on 96415 merits monitoring as a utilization outlier relative to national peers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

36 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1745	Injection, infliximab, excludes biosimilar, 10 mg	9,730	$30	$253K
J9312	Injection, rituximab, 10 mg	3,600	$60	$226.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	4,330	$30	$147.1K
J1602	Injection, golimumab, 1 mg, for intravenous use	14,450	$10	$144.5K
J3262	Injection, tocilizumab, 1 mg	16,080	$10	$80.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	430	$100	$44.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	390	$90	$34.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	50	$150	$7.4K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	330	$20	$7.3K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	460	$10	$3.7K

Showing 1–10 of 36

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 36 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Grace Skemp-dymond — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

36 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	15	20	5,330	$30	$242.9K
J9312	3	10	4,030	$60	$231.9K
J3262	14	20	26,440	$1	$147.6K
J1602	4	20	7,050	$10	$112K
J1745	2	60	1,540	$30	$76.7K
96413	8	230	70	$100	$11.5K
86235	10	20	100	$20	$11.2K
86480	12	10	40	$60	$9K
99214	294	10,100	70	$80	$8.1K
99215	2,197	4,060	30	$120	$5.9K

Showing 1–10 of 36

Related Providers

Other providers that share a Tax Identification Number (TIN) with Grace Skemp-dymond, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Archibald Skemp	MN	Rheumatology Physician	$1.1M	$0
Susan Leonard	MN	Rheumatology Physician	$1M	$0
Sara Baig	MN	Rheumatology Physician	$736.2K	$0
Hammad Bajwa	MN	Rheumatology Physician	$694.8K	$0
Kurt Zimmerman	MN	Rheumatology Physician	$672.4K	$0
Maren Hilton	MN	Rheumatology Physician	$648.8K	$0
Anne Wolff	MN	Rheumatology Physician	$541.6K	$0
Jeffrey Wilson	MN	Rheumatology Physician	$402.5K	$0
Angela Dahle	MN	Rheumatology Physician	$346.1K	$0
Nicholas Lebedoff	MN	Rheumatology Physician	$322.6K	$0

Nearby Providers

Other providers in the same ZIP code as Grace Skemp-dymond, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emergency Physicians Professional Association	MN	Emergency Medicine Physician	$0	$72.7M
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
Fairview Health Services	MN	General Acute Care Hospital	$0	$17.2M
Professional Resource Network - Prn - Corporation	MN	Home Health Agency	$0	$12.4M
Virtual Radiologic Professionals, LLC	MN	Diagnostic Radiology Physician	$0	$11.3M
Mental Health Systems PC	MN	Psychologist	$0	$11M
Premier Obgyn Of Minnesota PLLC	MN	Obstetrics & Gynecology Physician	$0	$7M
Noran Neurological Clinic P.A.	MN	Specialist	$0	$6M
Nura Surgical Center LLC	MN	Ambulatory Surgical Clinic/Center	$5.3M	$581.7K
Southdale Pediatric Associates, Ltd	MN	Multi-Specialty Clinic/Center	$0	$5.3M

Grace Skemp-dymond — Billing Profile & Reimbursement Data

Sign up for Grace Skemp-dymond — Billing Profile & Reimbursement Data policy alerts

Grace Skemp-dymond — Billing Profile & Reimbursement Data

Sign up for Grace Skemp-dymond — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References